| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 47.726 | 45.247 | 9.156 | 45.590 | 47.796 | 66.983 | 90.926 | 97.563 | 257.459 |
| Total Income - EUR | - | 47.726 | 45.247 | 9.156 | 45.590 | 47.796 | 66.983 | 90.926 | 97.563 | 257.459 |
| Total Expenses - EUR | - | 455 | 964 | 0 | 5.498 | 5.272 | 2.670 | 2.332 | 9.088 | 47.588 |
| Gross Profit/Loss - EUR | - | 47.271 | 44.282 | 9.156 | 40.092 | 42.524 | 64.313 | 88.594 | 88.474 | 209.872 |
| Net Profit/Loss - EUR | - | 45.839 | 42.925 | 9.156 | 38.724 | 41.090 | 62.467 | 85.867 | 87.499 | 203.544 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 |
Check the financial reports for the company - Cissa Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 1.050 | 1.790 | 2.339 |
| Current Assets | - | 46.207 | 113.396 | 120.471 | 120.799 | 50.112 | 87.771 | 101.718 | 101.044 | 215.999 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 49.553 | 57.800 | 14.849 | 39.280 | 779 | 9.319 | 89.443 | 10.761 |
| Cash | - | 46.207 | 63.843 | 62.671 | 105.950 | 10.832 | 86.992 | 92.399 | 11.601 | 205.238 |
| Shareholders Funds | - | 45.884 | 88.350 | 95.885 | 111.130 | 41.131 | 62.507 | 85.907 | 87.539 | 203.584 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 324 | 25.046 | 24.586 | 9.669 | 8.980 | 25.264 | 16.860 | 15.295 | 14.754 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Cissa Med Srl